Share of insulin pump users among insulin dependent diabetes patients 2000-2010

This statistic depicts the percentage of insulin dependent diabetes patients in the United States that used an insulin pump from 2000 to 2010. In 2003, four percent of these patients used an insulin pump. Although, insulin pump users may have a higher upfront cost than self-injection, however, people who use insulin pumps tend to require emergency rooms less often and avoided long-term side effects such as kidney failure. Insulin dependent diabetes patientsThe United States spent about 239 billion U.S. dollars in 2013 for the treatment of diabetes. The number of deaths due to diabetes mellitus in the country has also seen a slight decrease from 25 per 100,000 people in 2000 to 20.8 per 100,000 people in 2010. However, the number of diagnosed cases has increased. In 2000, 12 million individuals in the U.S. were diagnosed and the number had risen to 20.9 million diagnosed individuals by 2011. There has been an increase of diabetes patients that use insulin pumps in the United States. In 2000, approximately 2.7 percent of insulin-dependent patients in the U.S. used insulin pumps, in 2010, insulin pump share increased to 7.1 percent. Insulin pump users may be more cost-effective than those who do not use a pump. In 2010, U.S. patients who used an insulin pump had an economic impact of 24,900 U.S. dollars per person, compared to 30,400 U.S. dollars per patient who did not use an insulin pump. Insulin pumps can be beneficial as they eliminate the need for individual insulin injections, provide more accurate insulin deliveries, can prevent large fluctuations in blood glucose levels, and allow for more flexibility in diet, among other benefits. However, insulin pumps can cause skin infection at the catheter site, create a risk of diabetic ketoacidosis due to malfunction or absorption issues, and can be expensive.

本统计数据描绘了2000年至2010年间美国胰岛素依赖型糖尿病患者使用胰岛素泵的比例。在2003年，此类患者中有4%使用了胰岛素泵。尽管胰岛素泵的使用者在初期成本上可能高于自我注射，然而，使用胰岛素泵的人群往往能减少对急诊室的频繁需求，并避免长期副作用，如肾功能衰竭。美国胰岛素依赖型糖尿病患者在美国的治疗费用在2013年约为2390亿美元。由于糖尿病引起的死亡人数在国家层面也有所下降，从2000年的每10万人25例降至2010年的每10万人20.8例。然而，确诊病例的数量有所上升。2000年，美国有1200万人被诊断出患有糖尿病，到2011年这一数字上升至2090万人。美国使用胰岛素泵的糖尿病患者数量有所增加。2000年，美国约2.7%的胰岛素依赖型患者使用胰岛素泵，到2010年，胰岛素泵的使用比例上升至7.1%。使用胰岛素泵的患者可能在经济上更为高效。2010年，使用胰岛素泵的美国患者每人产生的经济影响为24,900美元，而未使用泵的患者每人产生的经济影响为30,400美元。胰岛素泵的益处在于它们消除了对单独胰岛素注射的需求，提供更准确的胰岛素输送，可以防止血糖水平的剧烈波动，并在其他方面提供更多饮食上的灵活性。然而，胰岛素泵可能在导管部位引起皮肤感染，由于故障或吸收问题而增加糖尿病酮症酸中毒的风险，并且可能成本高昂。